Exploring the Potential of Stem Cell Therapy and Non-Opioid Anesthesia and Pain Reduction: Reducing the Negative Impact on the Individual and Society

Author:

Kerna Nicholas A.ORCID,Flores John V.ORCID,Azi Cornelius I.ORCID,Carsrud N.D. VictorORCID,Chawla SudeepORCID,Pruitt Kevin D.ORCID,Anderson II JosephORCID,McKee DevinORCID,Ngwu Dabeluchi C.ORCID

Abstract

The opioid epidemic poses a significant public health challenge, stemming from the widespread misuse and abuse of opioids for pain management. Stem cell therapy (SCT) and non-opioid anesthesia emerge as promising alternatives to traditional opioid-based treatments, offering effective pain relief while mitigating the risks of addiction and overdose. SCT involves undifferentiated cells, which can differentiate into various cell types to promote tissue repair and alleviate pain. Non-opioid anesthesia employs techniques such as regional anesthesia and multimodal analgesia to manage pain during surgeries without relying on opioids.Both SCT and non-opioid anesthesia demonstrate advantages in reducing opioid dependence and improving patient outcomes. SCT releases neurotrophic factors for neuropathic pain relief and can prevent opioid tolerance, while non-opioid anesthesia provides robust pain control with fewer side effects.Although further research is needed to optimize their use, the integration of SCT and non-opioid anesthesia affords a comprehensive approach to addressing the opioid crisis. By reducing opioid prescriptions and promoting safer pain management practices, these interventions not only benefit individual patients but also alleviate the socioeconomic burden of opioid-related complications. Ethical considerations, such as informed consent and patient autonomy, are essential in ensuring these alternative treatments’ responsible and equitable implementation. SCT and non-opioid anesthesia represent significant advancements in combating the opioid epidemic and improving public health outcomes.Abbreviations: CPSP: Chronic Post-Surgical Pain; ESCs: Embryonic Stem Cells; HSCs: Hematopoietic Stem Cells; MSCs: Mesenchymal Stem Cells; NSAIDs: Nonsteroidal Anti-Inflammatory Drugs; OFA: Opioid-Free Anesthesia; PONV: Postoperative Nausea and Vomiting; QoL: Quality of Life; SCT: Stem Cell Therapy; TKA: Total Knee Arthroplasty

Publisher

AMO Publisher

Reference62 articles.

1. Phillips JK, Ford MA, Bonnie RJ. Pain Management and the Intersection of Pain and Opioid Use Disorder. In: Pain Management and the Opioid Epidemic: Balancing Societal and Individual Benefits and Risks of Prescription Opioid Use. National Academies Press; 2017.

2. Fala L, Welz JA. New Perspectives in the Treatment of Opioid-Induced Respiratory Depression. PubMed [Internet]. 2015 Oct 1;8(6 Suppl 3):S51-63.

3. Damiescu R, Banerjee M, Lee DYW, Paul NW, Efferth T. Health(care) in the Crisis: Reflections in Science and Society on Opioid Addiction. International Journal of Environmental Research and Public Health [Internet]. 2021 Jan 5;18(1):341. Doi: 10.3390/ijerph18010341

4. Dydyk AM, Jain NK, Gupta M. Opioid Use Disorder. In: StatPearls. StatPearls Publishing; 2024.

5. Bohringer CH, Astorga C, Liu H. The benefits of opioid free anesthesia and the precautions necessary when employing it. Translational Perioperative and Pain Medicine [Internet]. 2019 Oct 18;7(1). Doi: 10.31480/2330-4871/104

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3